Topics

Glioblastoma | Treatment | Clinical trials | Lenvatinib

Home > Publications > Topics > Glioblastoma > Treatment > Clinical trials > Lenvatinib

Rha SY, Castanon E, Gill S, Senellart H, Lopez J, Márquez-Rodas I, Victoria I, Kim TM, Lwin Z, Burger MC, Simonelli M, Cassier PA, Hendifar AE, Ascierto PA, Dutcus C, Okpara CE, Ghori R, Jin F, Groisberg R, Villanueva L.
Lenvatinib plus pembrolizumab for patients with previously treated select solid tumors: Results from the phase 2 LEAP-005 study recurrent glioblastoma cohort.
Cancer. 2025 Aug 15;131(16):e70015. doi: 10.1002/cncr.70015. PMID: 40808295. Interventional study. ˍ ClinicalTrials.gov ID: NCT03797326.